Genomictree Inc. (KOSDAQ: A228760)
Health Care · Biotechnology · KR
₩11,320.00
-7.21% today · -43.1% 1Y
Genomictree Inc. (KOSDAQ: A228760) operates in the Biotechnology industry within the Health Care sector. The company is valued at $206.67M.
Over the last twelve months the share price has lost 43.1%, trading between 9.93K and 33.30K.
Tweenvest scores Genomictree Inc. across four factors: quality 55/100, value 53/100. Its strongest factor is quality.
A228760 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $206.67M
- Revenue (TTM)
- $1.90M
- P/E
- —
- EPS
- -373.14
- Dividend yield
- —
- Beta (5Y)
- 0.09
- 52-week high
- ₩33,300.00
- 52-week low
- ₩9,930.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.54M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Invivyd, Inc.NasdaqGM: IVVD | $212.58M | $0.67 | -6.64% |
| Guangzhou Innogen Pharmaceutical Group Co., LtdSEHK: 2591 | $209.56M | HK$3.60 | -3.49% |
| HLB Therapeutics Co.,Ltd.KOSDAQ: A115450 | $208.16M | ₩3,175.00 | +28.54% |
| TaiGen Biopharmaceuticals Holdings LimitedTPEX: 4157 | $207.71M | NT$9.33 | +7.86% |
| Shanghai Rightongene Biotechnology Co., Ltd.SHSE: 688217 | $204.58M | CN¥24.83 | -3.20% |
| Anbio BiotechnologyNasdaqGM: NNNN | $204.53M | $4.41 | -5.36% |
| Entrada Therapeutics, Inc.NasdaqGM: TRDA | $204.44M | $5.50 | -3.00% |
| Exagen Inc.NasdaqGM: XGN | $203.98M | $8.25 | -2.02% |
Figures last refreshed Oct 11, 2026.